NBQX
SKU
N-1019
- CAS:118876-58-7
- Formula:C12H8N4O6S
- MW:336.28
- Appearance:Pale yellow to yellow powder
- Purity:>99%
SDS
CofA
Potent and selective AMPA/Kainate receptor antagonist. Neuroprotective agent.
For water soluble product, refer to NBQX disodium salt
* Listed below are a few published articles demonstrating the use of our NBQX. Inquire for a full list of references.
- Age-Dependent Alterations of Corticostriatal Activity in the YAC128 Mouse Model of Huntington Disease, Prasad R. Joshi, Nan-Ping Wu, et al, J. Neurosci., Feb 2009; 29: 2414 - 2427.
- Dopamine Modulates Release from Corticostriatal Terminals, Nigel S. Bamford, et al, J. Neurosci., Oct 2004; 24: 9541 - 9552
- Development of Behavioral Sensitization to the Cocaine-Like Fungicide Triadimefon Is Prevented by AMPA, NMDa, DA D1 but Not DA D2 RECEPTOR Antagonists, R. Reeves, et al, Toxicol. Sci., May 2004; 79: 123 - 136.
More Information
SKU
N-1019
CAS #
118876-58-7
Chemical Name
2,3-Dihydroxy-6-nitro-7-sulphamoylbenzo(f)-quinoxaline 6-Nitro-7-sulphamoylbenzo(f)-quinoxaline-2,3-dione
Chemical Formula
C12H8N4O6S
Molecular Weight
336.28
Appearance
Pale yellow to yellow powder
Purity
>99%
Solubility
Soluble in DMSO. Dilute with buffer, pH 7.5.
Storage Temp
+4°C, Store in Tightly Sealed Vial. Product can be stored at -20C as well.
Citations
NEUROBIOLOGY OF DISEASE:
Age-Dependent Alterations of Corticostriatal Activity in the YAC128 Mouse Model of Huntington Disease
Prasad R. Joshi, Nan-Ping Wu, Véronique M. André, Damian M. Cummings, Carlos Cepeda, John A. Joyce, Jeffrey B. Carroll, Blair R. Leavitt, Michael R. Hayden, Michael S. Levine, and Nigel S. Bamford
J. Neurosci., Feb 2009; 29: 2414 - 2427.
Citations_Hyperlink
http://www.jneurosci.org/cgi/reprint/29/8/2414
Certificate of Analysis 1
Certificate of Analysis 2
| GHS PICTOGRAMS |
|
|---|